UBS Group AG - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 18 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q4 2022$751,255
+132.0%
0.00%
Q1 2022$0
-100.0%
541
-54.0%
0.00%
Q3 2021$1,000
-50.0%
1,175
-39.4%
0.00%
Q2 2021$2,000
-66.7%
1,938
-62.2%
0.00%
Q1 2021$6,0005,1330.00%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q3 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 66,666$656,0000.02%
Altium Capital Management LP 133,333$25,0000.01%
Radcliffe Capital Management, L.P. 33,333$329,0000.01%
Granite Point Capital Management, L.P. 133,332$25,0000.01%
COWEN AND COMPANY, LLC 187,227$35,0000.00%
683 Capital Management, LLC 200,000$37,0000.00%
KINGDON CAPITAL MANAGEMENT, L.L.C. 66,665$11,0000.00%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 333,333$62,0000.00%
HealthCor Management, L.P. 78,059$15,0000.00%
CVI Holdings, LLC 115,985$20,0000.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders